Lsv Asset Management Exelixis, Inc. Transaction History
Lsv Asset Management
- $41.9 Billion
- Q2 2025
A detailed history of Lsv Asset Management transactions in Exelixis, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 7,820,447 shares of EXEL stock, worth $293 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
7,820,447
Previous 8,161,338
4.18%
Holding current value
$293 Million
Previous $301 Million
14.41%
% of portfolio
0.82%
Previous 0.72%
Shares
16 transactions
Others Institutions Holding EXEL
# of Institutions
680Shares Held
260MCall Options Held
1.32MPut Options Held
1.5M-
Black Rock Inc. New York, NY33.5MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.03 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$602 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$594 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$427 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...